Icure Pharmaceutical Incorporation (KOSDAQ: 175250)

Icure Pharmaceutical Incorporation Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,485	6,332	50,569	17,806	5,913	7,987
Short-Term Investments	250	340.19	360.19	745	2,113	11,000
Trading Asset Securities	2,281	1,886	2,856	5,866	5,692	17,187
Cash & Short-Term Investments	9,016	8,558	53,786	24,417	13,718	36,175
Cash Growth	-35.88%	-84.09%	120.28%	77.99%	-62.08%	-32.31%
Accounts Receivable	7,194	7,726	8,174	10,153	12,406	12,745
Other Receivables	357.49	194.11	509.92	1,774	1,621	2,077
Receivables	9,741	8,760	15,884	16,978	17,127	14,827
Inventory	12,689	13,019	10,546	16,977	12,089	14,167
Prepaid Expenses	487.74	116.21	80.58	129.48	114.17	72.48
Other Current Assets	311.25	654.81	408.36	294.83	677.36	1,576
Total Current Assets	32,244	31,108	80,705	58,796	43,726	66,817
Property, Plant & Equipment	69,162	93,526	96,943	101,312	107,813	97,306
Long-Term Investments	7,889	9,416	11,001	22,675	10,904	12,238
Goodwill	2,858	2,858	2,858	4,150	4,119	4,276
Other Intangible Assets	1,936	2,381	2,980	3,081	3,850	5,569
Long-Term Accounts Receivable	-	-0	-	-	-	-
Long-Term Deferred Tax Assets	838.13	774.48	530.59	-	-	-
Long-Term Deferred Charges	8,520	9,020	9,701	8,622	7,879	4,581
Other Long-Term Assets	33,704	17,053	18,412	16,794	16,839	21,058
Total Assets	157,152	166,137	224,121	215,448	195,149	211,898
Accounts Payable	4,609	7,291	6,461	6,155	4,829	7,274
Accrued Expenses	721.69	755.32	718.82	496.54	656.63	676.39
Short-Term Debt	68,817	68,630	73,521	10,050	18,112	9,488
Current Portion of Long-Term Debt	2,879	2,805	3,747	32,120	120	5,700
Current Portion of Leases	49.16	77.56	171.09	185.44	147.81	253.93
Current Income Taxes Payable	-	-	-	-	334.75	339.93
Current Unearned Revenue	-	106.08	23.75	-	-	-
Other Current Liabilities	15,361	15,774	25,339	5,811	9,909	13,056
Total Current Liabilities	92,438	95,439	109,981	54,818	34,110	36,787
Long-Term Debt	4,343	4,862	9,450	31,650	40,228	67,651
Long-Term Leases	70.56	34.72	120.83	180.31	189.66	1,366
Long-Term Deferred Tax Liabilities	-	-	-	16.36	487.43	913.66
Other Long-Term Liabilities	2,971	2,852	9,833	27,615	2,249	956.03
Total Liabilities	103,314	106,545	132,262	116,744	80,410	111,578
Common Stock	18,779	18,779	18,779	9,446	3,775	3,223
Additional Paid-In Capital	133,428	133,401	133,434	107,271	92,050	65,787
Retained Earnings	-97,048	-91,892	-60,603	-18,969	19,027	31,420
Treasury Stock	-3,707	-3,707	-3,707	-3,160	-3,160	-3,160
Comprensive Income & Other	1,457	1,657	1,769	1,168	461.98	260.29
Total Common Equity	52,909	58,238	89,671	95,755	112,154	97,531
Minority Interest	928.95	1,355	2,188	2,949	2,584	2,789
Shareholders' Equity	53,838	59,593	91,859	98,704	114,738	100,320
Total Liabilities & Equity	157,152	166,137	224,121	215,448	195,149	211,898
Total Debt	76,159	76,409	87,009	74,186	58,797	84,459
Net Cash (Debt)	-67,143	-67,851	-33,224	-49,769	-45,079	-48,284
Net Cash Per Share	-1791.53	-1806.54	-1426.23	-2298.37	-2283.92	-2658.82
Filing Date Shares Outstanding	37.37	37.37	37.37	22.51	17.8	18.19
Total Common Shares Outstanding	37.37	37.37	37.37	22.51	21.36	18.19
Working Capital	-60,193	-64,331	-29,276	3,979	9,616	30,030
Book Value Per Share	1415.83	1558.42	2399.56	4254.76	5249.92	5362.89
Tangible Book Value	48,115	52,998	83,832	88,524	104,185	87,685
Tangible Book Value Per Share	1287.54	1418.22	2243.32	3933.45	4876.90	4821.52
Land	8,305	25,626	24,378	25,388	25,614	24,035
Buildings	47,244	52,384	52,053	50,835	52,013	30,531
Machinery	36,177	36,265	33,830	30,572	34,641	29,333
Construction In Progress	247.19	259.66	917.82	3,422	1,513	20,774

Source: S&P Capital IQ. Standard template. Financial Sources.